Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer
Authors
Keywords
Breast cancer, Tamoxifen resistance, HBXIP, HOXB13, Acetylation, Chaperone-mediated autophagy
Journal
Journal of Hematology & Oncology
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-23
DOI
10.1186/s13045-018-0577-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade
- (2016) Y. Zhao et al. CANCER RESEARCH
- OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells
- (2016) S Bhatt et al. ONCOGENE
- The oncoprotein HBXIP promotes migration of breast cancer cells via GCN5-mediated microtubule acetylation
- (2015) Leilei Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc
- (2015) Yinghui Li et al. CANCER RESEARCH
- The Oncoprotein HBXIP Modulates the Feedback Loop of MDM2/p53 to Enhance the Growth of Breast Cancer
- (2015) Hang Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endocrine resistance in breast cancer – An overview and update
- (2015) Robert Clarke et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth
- (2015) L Li et al. ONCOGENE
- Disruption of chaperone-mediated autophagy-dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization
- (2014) Li Zhang et al. Autophagy
- The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling
- (2014) Yinghui Li et al. CANCER LETTERS
- The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF
- (2014) Fabao Liu et al. CARCINOGENESIS
- An epigenomic approach to therapy for tamoxifen-resistant breast cancer
- (2014) Qin Feng et al. CELL RESEARCH
- Emergence of Constitutively Active Estrogen Receptor- Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
- (2014) R. Jeselsohn et al. CLINICAL CANCER RESEARCH
- Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer
- (2014) P-P Wong et al. ONCOGENE
- Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents - implications for cancer treatment and chemoprevention
- (2014) Eugenia Yiannakopoulou CELLULAR ONCOLOGY
- Lysine-5 Acetylation Negatively Regulates Lactate Dehydrogenase A and Is Decreased in Pancreatic Cancer
- (2013) Di Zhao et al. CANCER CELL
- D538G Mutation in Estrogen Receptor- : A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
- (2013) K. Merenbakh-Lamin et al. CANCER RESEARCH
- HOXB13 Mediates Tamoxifen Resistance and Invasiveness in Human Breast Cancer by Suppressing ER and Inducing IL-6 Expression
- (2013) N. Shah et al. CANCER RESEARCH
- Sox2 promotes tamoxifen resistance in breast cancer cells
- (2013) Marco Piva et al. EMBO Molecular Medicine
- Tamoxifen resistance: From bench to bedside
- (2013) Marjolein Droog et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- HOXB13 downregulates intracellular zinc and increases NF-κB signaling to promote prostate cancer metastasis
- (2013) Y-R Kim et al. ONCOGENE
- Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1
- (2012) Liron Bar-Peled et al. CELL
- Acetylation-Dependent Regulation of Skp2 Function
- (2012) Hiroyuki Inuzuka et al. CELL
- Ubiquitination and selective autophagy
- (2012) S Shaid et al. CELL DEATH AND DIFFERENTIATION
- HBXIP upregulates CD46, CD55 and CD59 through ERK1/2/NF-κB signaling to protect breast cancer cells from complement attack
- (2012) Wenjing Cui et al. FEBS LETTERS
- The tumor suppressormicroRNA-29cis downregulated and restored by celecoxib in human gastric cancer cells
- (2012) Yoshimasa Saito et al. INTERNATIONAL JOURNAL OF CANCER
- HIF1α Protein Stability Is Increased by Acetylation at Lysine 709
- (2012) Hao Geng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Oncoprotein HBXIP Uses Two Pathways to Up-regulate S100A4 in Promotion of Growth and Migration of Breast Cancer Cells
- (2012) Shuangping Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Improving Endocrine Therapy for Breast Cancer: It's Not That Simple
- (2012) E. Claire Dees et al. JOURNAL OF CLINICAL ONCOLOGY
- Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?
- (2012) Karin Beelen et al. Nature Reviews Clinical Oncology
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
- (2012) G. Sitia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
- (2012) Levi A. Garraway et al. Cancer Discovery
- miR-520b Regulates Migration of Breast Cancer Cells by Targeting Hepatitis B X-interacting Protein and Interleukin-8
- (2011) Nan Hu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acetylation Targets the M2 Isoform of Pyruvate Kinase for Degradation through Chaperone-Mediated Autophagy and Promotes Tumor Growth
- (2011) Lei Lv et al. MOLECULAR CELL
- Prevention and treatment of bone metastases
- (2011) Robert E. Coleman Nature Reviews Clinical Oncology
- GOBO: Gene Expression-Based Outcome for Breast Cancer Online
- (2011) Markus Ringnér et al. PLoS One
- Role of Chaperone Mediated Autophagy (CMA) in the Degradation of Misfolded N-CoR Protein in Non-Small Cell Lung Cancer (NSCLC) Cells
- (2011) Azhar Bin Ali et al. PLoS One
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- HOXB13 May Predict Response to Neoadjuvant Letrozole in Patients with Estrogen Receptor-Positive Breast Cancer.
- (2010) X. Ma et al. CANCER RESEARCH
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Cytochrome P450 2D6 and Homeobox 13/Interleukin-17B Receptor: Combining Inherited and Tumor Gene Markers for Prediction of Tamoxifen Resistance
- (2008) M. P. Goetz et al. CLINICAL CANCER RESEARCH
- A Positive Feedback between Activated Extracellularly Regulated Kinase and Cyclooxygenase/Lipoxygenase Maintains Proliferation and Migration of Breast Cancer Cells
- (2008) Jiacong You et al. ENDOCRINOLOGY
- Autophagy fights disease through cellular self-digestion
- (2008) Noboru Mizushima et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now